1Heeringa J, van der Kuip D A, Hofman A, et al. Prevalence,inci- dence and lifetime risk of atrial fibrillation: the Rottendam study[J]. Eur Heart J, 2006, 27:949-953.
2Connolly S J, Ezekowitz M D, Yusuf S, et al. Dabigatran versus warfarin in in patients with atrial fibrillation[J]. N Engl Jmed, 2009, 361(12):1139-1151.
3Furberg C D, Psaty B M, Manolio T A, et al. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)[J]. Am J Cardiol, 1994, 74(3): 236-241.
6Craig T, January F, Samuel W, et al. 2014 AHA/ACC/HRS Guide- line for the Management of Patients With Atrial Fibrillation [J]. J Am Cell Cardiol, 2014,26: S0735-1097(14)01739-2.